Phenome India National Biobank Boosts Disease Research

PHENOME INDIA ‘NATIONAL BIOBANK’ INAUGURATED TO BOOST DISEASE RESEARCH

Why in the News?

  • Inauguration event: Dr. Jitendra Singh launched the Phenome India National Biobank in New Delhi.
  • Research boost: Hosted by CSIR-IGIB, it will collect genomic, lifestyle, and clinical data from 10,000 individuals.
  • Nationwide impact: Aims to support cohort-based research reflecting India’s ethnic, geographic, and socioeconomic diversity.

Phenome India National Biobank Boosts Disease Research

Key Features and Objectives

  • Disease targeting: Will help combat diabetes, cancer, heart diseases, and rare genetic disorders.
  • Early diagnosis: Supports early detection and precision treatment through rich biobank datasets.
  • Inclusive sampling: Covers diverse Indian populations, enabling comprehensive healthcare insights.

Significance for Science and Innovation

  • Tech leadership: Reinforces India’s progress in CRISPR, quantum tech, and AMR solutions.
  • Collaborative push: Dr. Singh urged integration of research, government, and industry for scalable impact.
  • Global standing: Positions India as a leader in biogenomics and personalised medicine research.

BIOMEDICAL BIOBANKS IN INDIA

●      Definition: Biobanks are structured repositories of biological samples for scientific research.

●      Types: Includes population-based, disease-specific, and tissue-specific biobanks.

●      Utility: Crucial for genomic studies, drug discovery, and clinical trials.

●      Indian examples: Include NIBMG, ICMR-National Biobank, and now Phenome India.

●      Policy framework: Governed by ICMR ethical guidelines and DBT standards for sample collection.